| Elizabeth Monteiro, MD | |
|
1 Washington St, Suite A, Taunton, MA 02780-3960 | |
| (508) 823-9921 | |
| (508) 824-6642 |
| Full Name | Elizabeth Monteiro |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 1 Washington St, Taunton, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447228515 | NPI | - | NPPES |
| 0119261 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 207313 (Massachusetts) | Primary |
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000332 |
News Archive
Youth exposure to alcohol advertising in magazines declined by 48 percent between 2001 and 2008, according to a new study by the Center on Alcohol Marketing and Youth at the Johns Hopkins Bloomberg School of Public Health.
"Will you help her?" That's the question the Campaign for Better Care, led by the National Partnership for Women & Families, Community Catalyst and the National Health Law Program, is asking policymakers today in new print and banner ads running in The Hill, Politico and Roll Call.
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a randomized Phase 2 study of its lead candidate, CRLX101, in patients with extensive-stage small cell lung cancer (SCLC) sensitive to first-line platinum-based chemotherapy.
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.
› Verified 1 days ago
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20200204002341 |
News Archive
Youth exposure to alcohol advertising in magazines declined by 48 percent between 2001 and 2008, according to a new study by the Center on Alcohol Marketing and Youth at the Johns Hopkins Bloomberg School of Public Health.
"Will you help her?" That's the question the Campaign for Better Care, led by the National Partnership for Women & Families, Community Catalyst and the National Health Law Program, is asking policymakers today in new print and banner ads running in The Hill, Politico and Roll Call.
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a randomized Phase 2 study of its lead candidate, CRLX101, in patients with extensive-stage small cell lung cancer (SCLC) sensitive to first-line platinum-based chemotherapy.
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Monteiro, MD Po Box 847348, Boston, MA 02284-7348 Ph: (508) 823-9921 | Elizabeth Monteiro, MD 1 Washington St, Suite A, Taunton, MA 02780-3960 Ph: (508) 823-9921 |
News Archive
Youth exposure to alcohol advertising in magazines declined by 48 percent between 2001 and 2008, according to a new study by the Center on Alcohol Marketing and Youth at the Johns Hopkins Bloomberg School of Public Health.
"Will you help her?" That's the question the Campaign for Better Care, led by the National Partnership for Women & Families, Community Catalyst and the National Health Law Program, is asking policymakers today in new print and banner ads running in The Hill, Politico and Roll Call.
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a randomized Phase 2 study of its lead candidate, CRLX101, in patients with extensive-stage small cell lung cancer (SCLC) sensitive to first-line platinum-based chemotherapy.
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.
› Verified 1 days ago
Priti A Patel, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 233 Winthrop Street, Taunton, MA 02780 Phone: 508-880-0070 Fax: 508-880-2989 | |
Robert J Mcnamee, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 72 Washington St, Suite 1300, Taunton, MA 02780 Phone: 508-824-5865 Fax: 508-823-9108 | |
Kabir Chuttani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 72 Washington St, Suite 1400-1700, Taunton, MA 02780 Phone: 508-880-0077 Fax: 508-880-5247 | |
Yun Xia, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Industrial Park Rd, Suite 1, Taunton, MA 02780 Phone: 508-822-2266 Fax: 508-823-5689 | |
Cristina Cellurale, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 91 Washington St Unit 301, Taunton, MA 02780 Phone: 508-824-5865 Fax: 508-823-9108 | |
Khalid A Zaalook, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Morton Hospital & Medical Center, 88 Washington Street, Taunton, MA 02780 Phone: 508-828-7293 | |
Yelena Levin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 152 Dean St, Taunton, MA 02780 Phone: 508-824-3872 Fax: 508-828-4925 |